KRTX News and Press, Karuna Therapeutics Inc. From 01/10/24

NEW YORK, NY / ACCESSWIRE / January 10, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: PGT Innovations, Inc. (NYSE:PGTI)'s ...

2024-01-08 14:41:28 ET More on Bristol-Myers Squibb Company Bristol-Myers Squibb Company (BMY) J.P. Morgan 42nd Annual Healthcare Conference (Transcript) Bristol-Myers Squibb Company (BMY) Goldman Sachs Healthcare C-Suite Unscripted Conference (Transcript) Bristol-My...

NEW YORK, NY / ACCESSWIRE / January 8, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: RayzeBio, Inc. (NASDAQ:RYZB)'s sale ...

NEW YORK, NY / ACCESSWIRE / January 4, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: RayzeBio, Inc. (NASDAQ:RYZB)'s sale ...

2024-01-03 17:17:52 ET Summary Bristol-Myers Squibb Company experienced a poor year in terms of share price performance in 2023, with a 27% decline in value. Bristol-Myers has focused on its late-stage pipeline and made several recent acquisitions geared towards offsetting losses ...

2024-01-03 07:53:17 ET More on Bristol-Myers Squibb Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation Bristol Myers Squibb: Too Many Headwinds To Ignore, Despite The Stellar Management Bristol Myers Squibb: Aggressive M&A, A Riskier Strat...

2024-01-03 07:00:00 ET Summary The biotech industry experienced a challenging year in 2023 due to a rising 10-year Treasury yield. In 2024, the 10-year yield should favorably support biotech stocks. Promising advancements in weight loss drugs, neuroscience, oncology, and gene ...

2024-01-01 15:37:15 ET More on AbbVie, Bristol-Myers Squibb Company , etc. Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation Bristol Myers Squibb: Too Many Headwinds To Ignore, Despite The Stellar Management Bristol Myers Squibb: Aggress...

2023-12-31 02:49:47 ET Summary Bristol-Myers Squibb is a well-known blue-chip stock with a dividend yield exceeding 4.6%. Since 2019, Bristol-Myers Squibb has acquired pharmaceutical companies worth more than $115 billion, allowing it to expand its drug portfolio and product candi...

2023-12-28 08:15:02 ET Canaccord Genuity analyst issues BUY recommendation for KRTX on December 28, 2023 08:35AM ET. The previous analyst recommendation was Buy. KRTX was trading at $317.16 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...